Clinical Trial Update: Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating glofitamab as monotherapy and in combination with polatuzumab vedotin, pirtobrutinib, or atezolizumab for Richter's transforma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Richter Transformation

Drugs mentioned

• Atezolizumab (atezolizumab)
• Glofitamab (glofitamab)
• Pirtobrutinib (pirtobrutinib)
• polatuzumab vedotin (polatuzumab vedotin)

Snippet

Sponsor: Christine Ryan | Conditions: Chronic Lymphocytic Leukemia, Richter's Transformation | Phase 2 | Status: RECRUITING